St. Luke's Mountain States Tumor Institute - Boise — Boise, Idaho

St. Luke's Mountain States Tumor Institute - Boise is a clinical research site located in Boise, Idaho, United States 83712.

Crixeo Clinical Trials Trust Score: 23/100 (FAILING). This profile has not yet been claimed by the site owner.

St. Luke's Mountain States Tumor Institute - Boise has participated in 25 clinical trials.

Therapeutic areas: Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Breast Cancer.

Sponsors: Children's Oncology Group, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, SWOG Cancer Research Network.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Boise

Browse all research sites in Idaho · View every site in Boise

Sponsor Feasibility Report

Trust Score: 23/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Mountain States Tumor Institute - Boise?

St. Luke's Mountain States Tumor Institute - Boise has a Crixeo Trust Score of 23/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Mountain States Tumor Institute - Boise conducted?

St. Luke's Mountain States Tumor Institute - Boise has 25 clinical trials on record. Their work covers Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Breast Cancer.

Is St. Luke's Mountain States Tumor Institute - Boise accredited by Crixeo Clinical Trials?

St. Luke's Mountain States Tumor Institute - Boise has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about St. Luke's Mountain States Tumor Institute - Boise?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.